Consultant in paediatric bone marrow transplantation at Great Ormond Street Hospital
Consultant in paediatric bone marrow transplantation at Great Ormond Street Hospital, with expertise in managing children with malignant and non-malignant disorders (immunodeficiencies/inborn errors metabolism).
Principal Investigator in phase II study on Pharmacokinetics of Treosulfan.
Principal Investigator in phase I study on Radio-immunotherapy with Yttrium-90.
Chief Investigator in phase 2 study on Radio-immunotherapy with Yttrium-90 in children with high risk leukaemia.
Principal Investigator in phase II study on use of Defibrotide in BMT.
Principal Investigator in phase II study on BMT in X-ALD.
Co-chief investigator in a phase 2 study on stem cell gene therapy in cerebral ALD.
Principal Investigator in phase 2 study on use of Nomacopan in paediatric TMA.
Principal Investigator in retrospective European study on BMT in CGD.
Immune reconstitution after umbilical cord blood transplantation.
Pharmacokinetics of Busulfan.
Co-investigator in phase I study on use of autologous CD19/22CAR-T cell therapy in ALL.
Co-investigator in phase II study on use of allo CD19 CAR T cell therapy in ALL
Lead on national anti-fungal guidelines in paediatric BMT
Visit website: https://www.gosh.ae/consultants/dr-robert-chiesa
See also: Great Ormond Street Hospital (GOSH) - Children's hospital for special care.
Robert Chiesa News
Therapeutic applications of base editing clears girl's leukemia
BBC - 11-Dec-2022
Base editing can soon be a part in taking control of our genomes to fight genetic diseasesRead more...